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Summary
Eczema is a common long-term condition, but inadequate support and informa-
tion can lead to poor adherence and treatment failure. We have reviewed the
international literature of interventions designed to promote self-management in
adults and children with eczema. MEDLINE, MEDLINE in process, Embase,
CINAHL and the Global Resource for EczemA Trials database were searched from
their inception to August 2016, for randomized controlled trials. Two authors
independently applied eligibility criteria, assessed risk of bias for all included
studies and extracted data. Twenty studies (3028 participants) conducted in 11
different countries were included. The majority (n = 18) were based in sec-
ondary care and most (n = 16) targeted children with eczema. Reporting of stud-
ies, including descriptions of the interventions and the outcomes themselves, was
generally poor. Thirteen studies were face-to-face educational interventions, five
were delivered online and two were studies of written action plans. Follow-up in
most studies (n = 12) was short term (up to 12 weeks). Only six trials specified
a single primary outcome. There was limited evidence of effectiveness. Only
three studies collected and reported outcomes related to cost and just one study
undertook any formal cost-effectiveness analysis. In summary, we have identified
a general absence of well-conducted and well-reported randomized controlled tri-
als with a strong theoretical basis. Therefore, there is still uncertainty about how
best to support self-management of eczema in a clinically effective and cost-effec-
tive way. Recommendations on design and conduct of future trials are presented.
What’s already known about this topic?
• Eczema requires a high degree of self-management by patients.
• Adherence to eczema treatments, and hence control of symptoms, can be poor.
• There is uncertainty about how best to support self-management in a clinically
effective and cost-effective way.
What does this study add?
• A wide range of interventions designed to promote self-management have been
evaluated in 20 studies across 11 different countries.
• Reporting of the design and conduct of these studies is generally poor, and explicit
theory describing how interventions are expected to improve care is uncommon.
• What works best for people with eczema and whether it is cost-effective is unknown.
• Recommendations for future trials are made.
Eczema is a long-term condition that usually begins in infancy
and can have a significant impact on patient quality of life.
Also referred to as atopic dermatitis and atopic eczema, the
World Allergy Organization suggests that the phenotype of
‘atopic eczema’ should be simply called ‘eczema’ unless speci-
fic IgE antibodies are demonstrated.1 Eczema is common and
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its prevalence is increasing. Approximately 20% of children in
industrialized countries have eczema, and in developing coun-
tries the prevalence is heading towards this figure.2 In adults,
population studies report an overall prevalence of 2–18%.3 It
is also a condition for which a high degree of self-care is
needed.4
Recently, there has been a policy shift in the U.K. towards
self-management for long-term conditions. Interventions to
improve patient (or carer) self-management of long-term con-
ditions are broadly designed to ‘increase the capacity, confi-
dence and efficacy of the individual’ to manage their health
on a day-to-day basis.5 Improved self-management has been
identified as key in improving disease outcomes and promot-
ing quality of life for people with long-term conditions.6
Effective treatment of eczema demands good self-management,
which, if established early on, could lead to considerable
improvement in quality of life. However, families of children
with eczema state that they do not receive adequate support
and information about symptom management.4 A lack of edu-
cation about therapy can lead to poor adherence (patients/car-
ers not using creams effectively) and treatment failure.7
In view of this, we sought to review the evidence on the
effectiveness of interventions designed to promote self-man-
agement for children, their caregivers and adults with eczema.
In particular, we wanted to answer the following questions:
What evidence is there that interventions designed to promote
self-management of atopic eczema are clinically effective and
cost-effective? What have the interventions evaluated to date
comprised? Has previous research established the contribution
of the different components of self-management interventions
to the outcomes assessed?
Materials and methods
We followed Preferred Reporting Items for Systematic reviews
and Meta-Analyses (PRISMA) guidelines8 and the protocol was
prospectively registered with PROSPERO (PROSPERO 2015:
CRD42015025314).9
Information sources and search strategy
We searched relevant databases (MEDLINE, MEDLINE In Pro-
cess, Embase, CINAHL and Global Resource for EczemA Tri-
als,10 from inception to August 2016) for randomized
controlled trials (RCTs) of interventions (delivered to children
with eczema, caregivers of children with eczema and adults
with eczema) that promote self-management. With the aid of
a medical information scientist, a search strategy was devel-
oped that included the following terms: eczema (and its syn-
onyms atopic eczema and atopic dermatitis), self-care, self-
management, education, patient education, action plan, treat-
ment plan and management plan (Appendix S1; see Support-
ing Information). Authors were contacted regarding further
trial publications and any unpublished studies and/or unpub-
lished data. Forward and backward searching was also con-
ducted within the reference lists of all included studies.
References from the searches were downloaded into End-
note (Endnote X7, Thomson Reuters, New York, NY, U.S.A.).
Two people independently screened all titles and abstracts
using the eligibility criteria. All included studies were accessed
in full and were screened by two reviewers independently.
The reasons for exclusion of all full-text trials were recorded
and any disagreements were resolved by the research team.
Eligibility criteria
We restricted our search to RCTs of interventions that pro-
mote patient/carer self-management in children (and/or their
caregivers, including parents) and adults with atopic eczema/
atopic dermatitis, compared with no intervention, usual care,
or an alternative intervention. The outcomes of primary inter-
est were effects on eczema severity and quality of life.
There is no agreed definition of self-management. There-
fore, based on the relevant literature,11–14 we defined a self-
management intervention as one that included one or more of
the features listed in Table 1. If a trial included patients with
other skin diseases, and the data for eczema could not be anal-
ysed separately, it was excluded. As our main outcomes of
interest were eczema severity and quality of life, we excluded
trials that did not include these outcomes.
Data extraction and risk of bias
A data extraction tool was developed and piloted. Data on
study design, description of intervention/comparison compo-
nents and outcomes were extracted independently, and in
duplicate, by two reviewers (A.J.L.K./E.L.R. and M.J.R.).
Authors were contacted to confirm missing data. Risk of bias
was conducted by two blinded reviewers (A.J.L.K./E.L.R.) and
checked by a third (M.J.R.), using the Cochrane Collabora-
tion’s risk of bias tool15 and Review Manager software (ver-
sion 53, Informer Technologies Inc., Roseau, Dominica).
Results
Study selection
After deduplication, 1895 titles and abstracts were screened
for eligibility and 33 full-text papers were assessed for
Table 1 Definition of interventions that promote patient/carer self-
management
• Imparts knowledge of the condition and/or its management
• Supports people in managing the social, emotional or
physical impacts of their conditions
• Involves patients/carers in decision-making
• Motivates people to self-manage (using targeted approaches
and/or structured support)
• Helps people to monitor their symptoms and know when
to take appropriate action, for example through the use
of written action plans
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eligibility (Fig. 1). After the exclusion of 10 papers, we
included 23 articles16–38 that described 20 RCTs. Two studies
were published in German25,27 and were translated for the
purpose of this review. Two articles were published as
research letters.23,32
Design, setting and participant recruitment
Participants were individually randomized in all 20
studies, which included a total of 3028 participants (Tables 2
and 3). The majority of studies were conducted in
Europe (n = 14) and the U.S.A. (n = 4). Most (n = 18) were
set in secondary care with participants recruited via
dermatology16,17,19,20,23–28,30,32,38 and paediatric outpatient
clinics.22,31,34,35,37
With the exception of two three-group trials,27,29 most
studies comprised two groups (intervention and comparison
groups). Only five studies27,29,34,35,37 gave details of any theo-
retical framework that underpinned intervention development
or possible mechanisms of effect.
Characteristics of participants
In the majority of studies (n = 16), the participants with
eczema were children, but two studies were of adults with
eczema,16,19 and two were of adults and children with
eczema.32,38 One study included participants with eczema,
psoriasis and other chronic skin diseases.19
Regarding inclusion criteria (Table 2), two studies stated
that participants had to have been diagnosed for at least 3
months28,35 and two studies specified 1 year.29,37 Twelve
studies did not specify any diagnostic criteria,23 and seven
studies included only participants with moderate38 or moder-
ate-to-severe eczema,17,22,25,28,34,35 although how this was
determined was not clear in three studies.17,22,38 In most stud-
ies of children, the caregivers were parents (three studies spec-
ify mothers),22,27,37 but in six studies the ‘caregiver’ was not
further described.23,29–32,35 Broberg et al.20 did not report par-
ticipant baseline characteristics.
Interventions and comparison groups
Of the studies aiming to improve the self-management
of eczema in children, only the caregivers of children with
eczema were the recipients of the intervention in eight
studies,17,22,23,26–29,31,34,37 while eight studies included chil-
dren with eczema and their caregiver.20,21,24,25,30,35 However,
this distinction was often not very well described.
The majority of interventions (13 studies) were face-to-face
educational interventions.19–22,24–28,30,31,34,35 Seven face-to-
face educational interventions were delivered to
groups,19,20,22,24,28,34,35 four were delivered to individu-
als,21,25,30,31 and two to a mixture of individuals and
groups.26,27 In one study, three different variations of inter-
vention were delivered according to the age of the child
(3 months to 7 years, 8–12 years and 13–18 years).35 The
duration and intensity of interventions varied from a one-off
15-min educational session,31 to 12 weekly 2-h sessions.19
Interventions were delivered by between one and four health
professionals including dermatologists, specialist dermatology
nurses, nurse practitioners and interdisciplinary teams.
Eighteen studies gave details on the type of health professional
delivering the intervention,16,17,19–22,25–32,34,35,37,38 three
stated the level of staff training16,21,31 and 13
studies16,19–22,26,28–31,34,35,38 stated the number of health pro-
fessionals that were involved in delivering the intervention.
Most studies of face-to-face education (n = 11) compared
their intervention with ‘usual care’,20,21,24–28,30,31,34,35
although this was often not made explicit and/or the specific
details of usual care were unclear.
Five studies were delivered via the internet,16,17,29,37,38 of
which three studies compared their intervention with ‘usual
care’.17,29,38 These varied from simple online videos16 and
educational modules29,37 to online consultations.17,38 The
2692 entries identified through 
database searches
(810 MEDLINE & MEDLINE in process, 1436 
Embase, 432 CINAHL, 14 GREAT database)
1895 title and abstracts
screened for eligibility
797 duplicate entries removed
1862 entries excluded
33 full-text articles
screened for eligibility 10 excluded
5 non-RCTs; 3 outcomes did not include eczema 
severity or QOL; 1 intervention not self-management;  
1 not child/adult with eczema
20 studies (23 papers) includedFig 1. Flowchart showing the flow of studies
through the systematic review.
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Table 2 Summary of included studies
Characteristic
Number of
studies Study (First author, year)
Country
U.S.A. 4 Armstrong et al. 2011, Shaw et al. 2008, Shi et al. 2013, Gilliam et al. 2016
Germany 4 Kardorff et al. 2003, Niebel et al. 2000, Staab et al. 2002, Staab et al. 2006
U.K. 2 Chinn et al. 2002, Santer et al. 2014
The Netherlands 2 Schuttelaar et al. 2009, van Os-Medendorp et al. 2012
Australia 2 Grillo et al. 2006, Moore et al. 2009
Norway 1 Bergmo et al. 2008
Belgium 1 Bostoen et al. 2012
Croatia 1 Pustisek et al. 2016
Sweden 1 Broberg et al. 1990
Japan 1 Futamura et al. 2013
Republic of Korea 1 Son et al. 2014
Setting
Secondary care 18 Armstrong et al. 2011, Bergmo et al. 2008, Bostoen et al. 2012, Broberg et al. 1990, Futamura
et al. 2013, Gilliam et al. 2016, Grillo et al. 2006, Kardorff et al. 2003, Moore et al. 2009,
Niebel et al. 2000, Pustisek et al. 2016, Schuttelaar et al. 2009, Shaw et al. 2008, Shi et al. 2013,
Staab et al. 2002, Staab et al. 2006, Son et al. 2014, van Os-Medendorp et al. 2012
Primary care 2 Chinn et al. 2002, Santer et al. 2014
Participants
Children only 16 Bergmo et al. 2008, Broberg et al. 1990, Chinn et al. 2002, Futamura et al. 2013, Gilliam et al.
2016, Grillo et al. 2006, Kardorff et al. 2003, Moore et al. 2009, Niebel et al. 2000, Pustisek
et al. 2016, Santer et al. 2014, Staab et al. 2002, Son et al. 2014, Schuttelaar et al. 2009, Shaw
et al. 2008, Staab et al. 2006
Adults only 2 Armstrong et al. 2011, Bostoen et al. 2012
Adults and children 2 Shi et al. 2013, van Os-Medendorp et al. 2012
Inclusion criteria
Eczema diagnosis
Not stated 12 Bergmo et al. 2008, Bostoen et al. 2012, Futamura et al. 2013, Gilliam et al. 2016, Grillo et al.
2006, Kardorff et al. 2003, Moore et al. 2009, Niebel et al. 2000, Shaw et al. 2008, Shi et al.
2013, Son et al. 2014, van Os-Medendorp et al. 2012
Hanifin and Rajka 5 Armstrong et al. 2011, Broberg et al. 1990, Pustisek et al. 2016, Staab et al. 2002, Staab et al.
2006
U.K. diagnostic criteria 2 Chinn et al. 2002, Schuttelaar et al. 2009
Clinical (GP diagnosis) 1 Santer et al. 2014
Minimum eczema severity
None 13 Armstrong et al. 2011, Bostoen et al. 2012, Broberg et al. 1990, Chinn et al. 2002, Gilliam et al.
2016, Grillo et al. 2006, Moore et al. 2009, Niebel et al. 2000, Santer et al. 2014, Schuttelaar
et al. 2009, Shaw et al. 2008, Shi et al. 2013, Son et al. 2014
Moderate 1 van Os-Medendorp et al. 2012 (not defined)
Moderate-to-severe 6 Bergmo et al. 2008 (not defined), Futamura et al. 2013 (not defined), Kardorff et al. 2003
(SCORAD of between 25 and 50), Pustisek et al. 2016 (SCORAD > 25), Staab et al. 2002
[(SCORAD > 20) for at least 4 months], Staab et al. 2006 (SCORAD ≥ 20)
Duration of follow-up
Not stated 1 Shi et al. 2013
2 weeks 1 Son et al. 2014
4 weeks 1 Moore et al. 2009
6 weeks 1 Kardorff et al. 2003
1–3 months 1 Shaw et al. 2008
2 months 1 Pustisek et al. 2016
12 weeks/3 months 6 Armstrong et al. 2011, Broberg et al. 1990, Chinn et al. 2002, Gilliam et al. 2016, Grillo et al.
2006, Santer et al. 2014
3–4 months 1 Niebel et al. 2000
6 months 1 Futamura et al. 2013
9 months 1 Bostoen et al. 2012
12 months 5 Bergmo et al. 2008, Schuttelaar et al. 2009, Staab et al. 2002, Staab et al. 2006, van Os-
Mendendorp et al. 2012
(continued)
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study by Santer et al.29 was a pilot trial that included a third
group in which healthcare professionals familiarized them-
selves with the intervention and, in a 20-min appointment,
encouraged participants to use the website as a resource to
help them manage their child’s eczema.
A written action plan was the intervention itself in two
studies,23,32 and was included as part of the educational pack-
age in a third.30
Duration of follow-up and collection of outcomes
Follow-up in most studies was between 2 weeks and
12 weeks.16,20,21,23,24,26,28,29,31,37,39 Seven studies included
longer follow-up periods of 6 months,22 9 months19 and 12
months.17,30,34,35,38 One study did not state the duration of
follow-up32 and two studies27,31 stated varying follow-up
intervals.
Outcomes
Only six of the 20 trials specified a single primary outcome
(Table 2).16,22,24,26,29,30 The studies by Staab et al. (2006),35
van Os-Medendorp et al.38 Pustisek et al.28 and Bostoen et al.19
specified two, three, four and five primary outcomes, respec-
tively. No primary outcome was specified in the other 10
studies.17,20,21,23,25,27,31,32,34,37
A wide range of other/secondary outcomes were also col-
lected, often using modified versions of published question-
naires, or unpublished and unvalidated scales. Only the
following three studies collected and reported any outcomes
related to cost: Staab et al. (2002)34 reported direct costs of
treatment; Bergmo et al.17 reported loss of employment;
Bergmo et al.17 and Bostoen et al.19 reported cost of contact
with healthcare professionals and prescription costs; and van
Os-Medendorp38 reported direct and indirect participant
costs. Only Bostoen et al.19 reported undertaking a formal
cost-effectiveness (cost-utility) analysis, and simply con-
cluded that their intervention (2-h group-based educational
sessions per week for 12 weeks) was not cost-effective at
6 months. It does not appear that separate analyses were
done for the 21 of 59 participants with atopic eczema in
this study.
We did not attempt to perform a meta-analysis because
there were not at least three similar studies with a low risk of
bias. In addition, data on outcomes (e.g. means, SDs) on
eczema severity and quality-of-life outcomes were often not
reported (a complete list is presented in Appendix S2 and
Appendix S3; see Supporting Information). We have summa-
rized the findings graphically in Figure 2 for these outcomes
where reported by two or more studies.
The available evidence suggests that the interventions devel-
oped and evaluated to date may improve both patient-reported
and objective measures of eczema severity but not quality of
life. The three web-based studies16,29,37 report changes in
Patient-Oriented Eczema Measure scores at 4–12 weeks near
or greater than the published minimal clinically important dif-
ference (MCID) of 3.40 However, the studies themselves are
quite different. Armstrong et al.16 compared an educational
video with an information leaflet for adults recruited from a
U.S. dermatology clinic; Santer et al.29 compared an educa-
tional website (with or without healthcare professional sup-
port) with usual U.K. primary care for caregivers of children
under 5 years and Son et al.37 recruited parents of children in
Korea under 3 years of age via a paediatric clinic to use a
Table 2 (continued)
Characteristic
Number of
studies Study (First author, year)
Primary outcomea
Not specified 10 Bergmo et al. 2008, Broberg et al. 1990, Chinn et al. 2002, Gilliam et al. 2016, Kardorff et al.
2003, Niebel et al. 2000, Shaw et al. 2008, Shi et al. 2013, Son et al. 2014, Staab et al. 2002
POEM 2 Armstrong et al. 2011, Santer et al. 2014
PO-SCORAD 1 Pustisek et al. 2016
SCORAD 6 Futamura et al. 2013, Grillo et al. 2006, Moore et al. 2009, Staab et al. 2006, Pustisek et al. 2016,
Bostoen et al. 2012
EASI 1 Bostoen et al. 2012
IDQOL/CDLQI 2 Schuttelaar et al. 2009, van Os-Medendorp et al. 2012
DLQI 2 van Os-Medendorp et al. 2012, Bostoen et al. 2012
Skindex-29 1 Bostoen et al. 2012
QoLIAD 1 Bostoen et al. 2012
‘Quality of life in
parents of children
with atopic eczema
questionnaire’
1 Staab et al. 2006
POEM, Patient-Oriented Eczema Measure; SCORAD, SCORing Atopic Dermatitis; PO-SCORAD, Patient-Oriented SCORAD; EASI, Eczema Area
and Severity Index; IDQOL, Infant’s Dermatitis Quality of Life Index; CDLQI, Children’s Dermatology Life Quality Index; DLQI, Dermatology
Life Quality Index. QoLIAD, Quality of Life Index for Atopic Dermatitis. aFour studies [Staab et al. (2006),35 van Os-Medendorp et al.,38 Pus-
tisek et al.28 and Bostoen et al.]19 specified multiple primary outcomes, therefore the column for this section does not add up to a total of 20.
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website, but did not describe what participants in their control
group received.
The face-to-face interventions trialled by Futamura et al.,22
Grillo et al.,24 Kardorff et al.,25 Pustisek et al.28 and Staab et al.35
all seem to decrease disease severity assessed by SCORing Ato-
pic Dermatitis (SCORAD) and, with the exception of Kardorff
et al. and the participants aged 13–18 years in the trial
reported by Staab et al., exceeded the published SCORAD
MCID of 87.41 While all of these studies were set in sec-
ondary care and examined interventions for children with
eczema, the interventions were different in their nature/inten-
sity (skin model,25 2-h workshop/education programme,24,28
2-day education programme,22 six 2-h education sessions),35
comparator groups (usual care,24,25,28,35 booklet)22 and had
different durations of follow-up (from 6 weeks to
12 months).
Risk of bias
Assessments regarding risk of bias in the included studies are
summarized graphically in Figure 3. These judgements were
difficult to make owing to the generally poor standard of
reporting. In trials of self-management interventions, it is not
possible to blind participants to their allocation. Therefore, the
majority of trials were graded as ‘high risk’ for this domain.
Six study authors did not state the funding source of their
study.16,17,20,25–27 When specified, the trials were mainly
funded by public bodies, with one funded by pharmaceutical
companies.19 Ten papers declared no conflict of inter-
est,16,19,22,23,28–30,32,35,38 nine did not state any conflict of
interest17,20,21,25–27,31,34,42 and the one ‘conflict of interest’
declared stated that the study was from an unpublished PhD
thesis.37
Discussion
We identified 20 RCTs of interventions that promote self-
management in people with eczema. Most studies had been
conducted in Europe or the U.S.A., were based in a hospital
setting and targeted children with eczema. The most common
type of intervention was face-to-face education, but there
were wide variations in the nature of these sessions, both in
terms of how they were delivered (individually, in groups, or
a mixture of both), who delivered them (from one ‘eczema
educator’ through to multidisciplinary teams) and their inten-
sity (from 15 min to a total of 24 h). Papers published more
recently have focused on interventions delivered via the inter-
net, but again the nature of these interventions varied signifi-
cantly. All interventions included information on symptom
and medication management.
Reporting was generally poor, making it difficult to inter-
pret the findings. Many studies did not specify any criteria for
eczema diagnosis. It was often not clear who the ‘caregiver’
was and the methods used to randomize patients were not sta-
ted. Interventions or usual care were often described poorly or
not at all and it was uncommon for any rationale or formal
theory to be given regarding the means by which interven-
tions were expected to effect change. The timing and means
of outcome data collection, where specified, were unclear;
unpublished or unvalidated measures were frequently
employed. Follow-up was generally short term (12 weeks or
less). The absence of any substantial evaluation of cost-effec-
tiveness is also notable.
We have conducted this review in accordance with current
recommendations, have published the review protocol with
PROSPERO9 and followed PRISMA guidelines for the reporting
of reviews evaluating randomized trials.8 All screening, data
extraction and risk of bias assessments were done by two
reviewers independently.
While it is still possible that we may have missed a relevant
study, we think this is unlikely because we independently
identified relevant studies cited by other related reviews (see
below). In the absence of any agreed definition of self-man-
agement, we developed and applied our own criteria based on
our reading of the literature. However, given the lack of detail
often provided by authors on the content of the different
interventions trialled, we consider this to be the safest
approach.
Our review complements and extends a number of related
reviews that have recently been published, which examine
the effect of psychological and educational interventions for
eczema on treatment adherence, disease severity and quality
of life.43–45 Our broader remit (all interventions designed to
promote self-management), strong critique of the methods
and reporting, and the inclusion of recently published trials
will help clinicians, researchers and commissioners better
understand what we know about interventions that might
help patients with eczema. However, unfortunately, we are
in agreement that there is still uncertainty about whether
educational interventions are effective in improving quality
of life for people with eczema;46 most studies of parental
education for eczema have been small and of poor quality;44
and it is unknown which particular components are clini-
cally effective and cost-effective in different clinical
settings.47
We are not alone in noting the ‘preponderance of small,
poorly reported and poorly conducted trials’,47 which is an
issue not confined to just this area of dermatology research.
McClean et al.48 have highlighted the problem specifically with
respect to statistical reporting. In keeping with the findings of
Alvarez et al.,49 we found that the standard of reporting was
generally better in papers published more recently. However,
uncertainty regarding the effectiveness of different interven-
tions to promote self-management will only be reduced by
better designed trials of adequate size reported in line with
guidance such as CONSORT50 and Statistical Analyses and
Methods in the Published Literature.51
In addition to improving the reporting of trials (Table 4),
researchers should recognize that all interventions to promote
self-management are complex, and their development,
description and evaluation should follow an appropriate
framework.52 Furthermore, interventions should be
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underpinned by an explicit theory regarding the mechanism
of action and preferably accompanied by a process evalua-
tion.53 Future studies should seek to evaluate interventions
that are pragmatic and tailored to the context and needs of the
recipients. In particular, research to date does not reflect the
fact that the majority of people with eczema have mild-to-
Online-only educaon
Outcome: eczema severity (POEM) 
Face-to-face educaon
Outcome: eczema severity (SCORAD) 
Outcome: quality of life 
Study or Subgroup
Armstrong 12 weeks
Santer Web only 12 weeks
Santer Web+HCP 12 weeks
Son 4 weeks
Mean
5·73
7·6
8·7
9·9
SD
3·71
6·1
7
2·31
Total
37
44
50
20
Mean
7·6
7·1
7·1
17·7
SD
3·83
6·6
6·6
7·06
Total
35
49
49
20
IV, Random, 95% CI
–1·87 [–3·61, –0·13]
0·50 [–2·08, 3·08]
1·60 [–1·08, 4·28]
–7·80 [–11·06, –4·54]
Mean differenceMean differenceComparatorIntervention
IV, Random, 95% CI
–100 –50 0 50 100
Study or Subgroup
Bostoen 36 weeks
Futamura 26 weeks
Grillo 12 weeks
Kardorff 6 weeks
Niebel 3–4 months
Pustisek 2 months
Staab (13–18 years) 52 weeks
Staab (3 months–7 years)
52 weeks
Staab (8–12 years)
52 weeks
Mean
33·91
15·4
23·52
14·1
36·91
23·08
23·4
23·7
25·8
SD
16·9
7·6
16·53
4·3
25·95
15·19
12·6
16·7
17·7
Total
8
28
30
15
15
64
70
274
102
Mean
34·47
27·8
40·21
19·8
32·33
36·44
35·2
28·4
32·6
SD
17·45
10·8
22·9
5·9
17·75
16·76
15·2
16·5
16·5
Total
8
28
28
15
14
64
50
244
83
IV, Random, 95% CI
–0·56 [–17·39, 16·27]
–12·40 [–17·29, –7·51]
–16·69 [–27·03, –6·35]
–5·70 [–9·39, –2·01]
4·58 [–11·51, 20·67]
–13·36 [–18·90, –7·82]
–11·80 [–16·94, –6·66]
–4·70 [–7·56, –1·84]
–6·80 [–11·74, –1·86]
Mean differenceMean differenceComparatorIntervention
IV, Random, 95% CI
–100 –50 0 50 100
Study or Subgroup
5.1.1 IDQOL
Grillo 12 weeks
Schuttelaar 52 weeks
5.1.2 CDLQI
Grillo 12 weeks
Schuttelaar 52 weeks
5.1.3 DFI
Futamura 26 weeks
Grillo 12 weeks
Schuttelaar 52 weeks
Mean
6·91
5·7
1·75
4·9
3·9
7·47
4
SD
5
5·4
1·16
3·5
3·7
5·79
4·8
Total
30
37
30
35
28
30
74
Mean
5·33
5·6
7·08
5·6
5·1
7·89
5·1
SD
3·02
3·9
4·52
4·2
4·8
5·85
5·5
Total
28
34
28
35
28
28
71
IV, Random, 95% CI
1·58 [–0·53, 3·69]
0·10 [–2·08, 2·28]
–5·33 [–7·05, –3·61]
–0·70 [–2·51, 1·11]
–1·20 [–3·44, 1·04]
–0·42 [–3·42, 2·58]
–1·10 [–2·78, 0·58]
Mean differenceMean differenceComparatorIntervention
IV, Random, 95% CI
–20 –10 0 10 20
Favours intervention Favours comparator
Favours intervention Favours comparator
Favours intervention Favours comparator
(a)
(b)
Fig 2. Forest plot of outcomes by intervention type. (a) Online-only education. (b) Face-to-face education. POEM, Patient-Oriented Eczema
Measure; CI, confidence interval; HCP, healthcare professional; SCORAD, SCORing Atopic Dermatitis; IDQOL, Infant’s Dermatitis Quality of Life
Index; CDLQI, Children’s Dermatology Life Quality Index; DFI, Dermatitis Family Impact Questionnaire.
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moderate disease and are managed in primary care. For exam-
ple, the needs and likely cost-effectiveness of an intervention
for preschool-age children is likely to be very different from
an intervention for adults with life-long disease. Despite being
recommended by guidelines, the evidence base for written
action plans is almost negligible54 and, as a potentially low-
cost intervention, warrants particular attention.
While our search and focus was on RCT evidence, the lack
of reference to, or use of, qualitative methods in intervention
development and evaluation was stark. One encouraging
exception to this was the pilot trial by Santer et al.,29 whose
study was supported by both a strong theoretical framework
(PRECEDE-PROCEED) and prior qualitative research. Future tri-
als should also include robust evaluations of the cost-effective-
ness of interventions.
What should clinicians draw from this review? Both inter-
net-based and face-to-face approaches probably improve self-
management and outcomes for patients, but the optimum
means of delivering support in a cost-effective way has yet to
be determined.
Fig 3. Risk of bias summary. Review authors’ judgements about each
risk of bias item for each included study.
Table 4 Recommendations to improve conduct and reporting of trials
of interventions to promote self-management in people with eczema
• All trials should be prospectively registered, with a trial
identifier and a protocol that conforms with CONSORT
guidelines published prior to completing participant recruit-
ment
• Authors should specify which, if any, eczema diagnostic cri-
teria was used and by whom these were administered
• Studies should clarify which population groups are partici-
pating in their trial and at whom the intervention is targeted
(children with eczema, caregivers of children with eczema,
adults with eczema) and the mechanism by which the
authors expect their intervention to work (e.g. improved
caregiver knowledge and confidence in use of topical treat-
ments, or improved adherence to treatment in adults with
eczema). Studies should state who in the family or otherwise
are the main caregivers of children with eczema
• The type, timing and intensity of the intervention should be
described in sufficient detail to enable its replication in clini-
cal practice, observing checklists such as TIDieR56
• The content of control and comparison groups needs to be
described in detail, even if the comparison group is ‘usual
care’ because this will vary between settings and countries
• Primary outcomes within studies need to be specified. Stud-
ies should be adequately powered in relation to this. Key
outcomes need to be appropriate and relevant to adults and
children with eczema and/or their caregivers
• Outcomes should include core outcomes (symptoms, signs,
quality of life, long-term control) as per Harmonizing Out-
comes Measures for Eczema (HOME) recommendations, to
enable comparisons across studies and the combination of
data in future systematic reviews
• The timing and method of collection of all outcomes should
be stated
• To reduce detection bias, researchers should give serious
consideration to collection of outcomes by an observer
blinded to allocation
• All trials should include an economic evaluation and where
appropriate, nested qualitative work and/or a process evalua-
tion
TIDieR, template for intervention description and replication.
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To return to our original questions, a mixture of different
interventions that might promote self-management have been
evaluated and there is evidence that some may be clinically
effective. However, it is unknown which components of these
interventions (e.g. patient–clinician relationship, use of writ-
ten action plan) are the most important and cost-effectiveness
has yet to be determined.
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